Noticias de OXUR.BR | Roxom Stocks

1 BTC

=

- USD

Loading market data...

OX

Cap. mercado

N/A

Volumen

146.69K

Próximos resultados

N/A

Gráfico Resultados Noticias Acerca de Insiders Reportes

Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular EdemaRegulated information – Inside information Despite Prior Positive Data, THR-149 Did Not Demonstrate Improvement in Vision Oxurion’s Board has Decided to Take Necessary Steps to File for Bankruptcy Leuven, BELGIUM, Boston, MA, US – November 20, 2023 – 7:00 am CET – Oxurion NV (Eur…globenewswire.com · Nov 20, 2023

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from AtlasRegulated Information - Denominator Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase. This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on…globenewswire.com · Nov 19, 2023

Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This YearLeuven, BELGIUM, Boston, MA, US – November 16, 2023 – 7 pm CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced today that it h…globenewswire.com · Nov 16, 2023

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from AtlasRegulated Information - Denominator Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on…globenewswire.com · Nov 16, 2023

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLCRegulated Information Leuven, BELGIUM, Boston, MA, US – November 15, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, to…globenewswire.com · Nov 15, 2023

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from AtlasRegulated Information - Denominator Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on…globenewswire.com · Nov 6, 2023

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from AtlasRegulated Information - Denominator Atlas Special Opportunities, LLC has converted 2 convertible bonds in Oxurion resulting in a EUR 50,000 capital increase. This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on …globenewswire.com · Nov 3, 2023

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLCRegulated Information Leuven, BELGIUM, Boston, MA, US – October 30, 2023 – 8.00 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, tod…globenewswire.com · Oct 30, 2023

Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI TrialLeuven, BELGIUM, Boston, MA, US – October 25, 2023 – 8 am CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced today that it ha…globenewswire.com · Oct 25, 2023

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from AtlasRegulated Information - Denominator Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on…globenewswire.com · Oct 20, 2023

OX

OXUR.BROXUR.BR

OXUR.BR

Pagar con—

Empezar a operar

Saldo disponible0,00

Tu posiciónAún no tienes OXUR.BR.

Tickers relacionados

Resultados